QA: Cellectar Biosciences Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2019_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001279704')"}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc.

  xvar xval
0 AssetsCurrent 13,951,834
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 543,339
3 remainder_Assets 558,909
4 LiabilitiesCurrent 1,622,122
5 LiabilitiesNoncurrent 170,999
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,820,073
9 ResearchAndDevelopmentExpense 6,835,229
10 remainder_Expenses 1,675,462
11 remainder_Revenues 0
12 remainder_NetIncome 91,737
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,054,082
1 Liabilities 1,793,121
2 Expenses 13,330,764
3 Revenues 0
4 StockholdersEquity 13,260,961
5 NetIncome -13,239,027
6 ComprehensiveNetIncome -13,239,027
7 BaseVar 15,134,852
8 EconomicCapitalRatio 1.14

Edgar->Model Mapping

Feature Distribution

Change over Time